Akebia Therapeutics
(AKBA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2006 | 12-2005 | |
| Operating Expenses | 37,940 | 15,933 | 8,523 | 0 | 0 |
| Operating Income | -37,940 | -15,933 | -8,523 | N/A | N/A |
| Other Income | 906 | 2,766 | 327 | 0 | 0 |
| Pre-tax Income | -37,034 | -13,167 | -8,196 | 0 | 0 |
| Net Income Continuous | -37,034 | -13,167 | -8,196 | N/A | N/A |
| Net Income | $-37,034 | $-13,167 | $-8,196 | $N/A | $N/A |
| EPS Basic Total Ops | -8.04 | -126.94 | -27.82 | N/A | N/A |
| EPS Basic Continuous Ops | -2.40 | -24.20 | -19.79 | N/A | N/A |
| EPS Diluted Total Ops | -8.04 | -126.94 | -27.82 | N/A | N/A |
| EPS Diluted Continuous Ops | -2.40 | -24.20 | -19.79 | N/A | N/A |
| EBITDA(a) | $-37,623 | $-15,172 | $-6,852 | $N/A | $N/A |